Katherine M. Bever

7.8k total citations
25 papers, 864 citations indexed

About

Katherine M. Bever is a scholar working on Oncology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Katherine M. Bever has authored 25 papers receiving a total of 864 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 10 papers in Immunology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Katherine M. Bever's work include Cancer Immunotherapy and Biomarkers (14 papers), Immunotherapy and Immune Responses (7 papers) and Genetic factors in colorectal cancer (5 papers). Katherine M. Bever is often cited by papers focused on Cancer Immunotherapy and Biomarkers (14 papers), Immunotherapy and Immune Responses (7 papers) and Genetic factors in colorectal cancer (5 papers). Katherine M. Bever collaborates with scholars based in United States and China. Katherine M. Bever's co-authors include José L. Avalos‬, Cynthia Wolberger, Dung T. Le, Elizabeth M. Jaffee, Robert A. Anders, Lei Zheng, Daniel A. Laheru, Michael S. Cosgrove, Elaine Bigelow and Xiangbin Zhang and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Molecular Cell.

In The Last Decade

Katherine M. Bever

22 papers receiving 854 citations

Peers

Katherine M. Bever

ONCOL

IMMUN

EPIDE

Antonio Lucena-Cacace Spain

Jianbing Hou China

Yvonne Vercoulen Netherlands

Yang Brooks United States

Guanghua Chen China

Saurabh V. Laddha United States

Vincent Klump United States

Quentin McAfee United States

James R. Knabb United States

Qiqiang Guo China

Antonio Lucena-Cacace Spain

Katherine M. Bever

261 ×0.6

ONCOL

365 ×1.2

110 ×0.4

47 ×0.3

IMMUN

78 ×0.5

EPIDE

Citations per year, relative to Katherine M. Bever Katherine M. Bever (= 1×) peers Antonio Lucena-Cacace

Countries citing papers authored by Katherine M. Bever

Since Specialization

Citations

This map shows the geographic impact of Katherine M. Bever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine M. Bever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine M. Bever more than expected).

Fields of papers citing papers by Katherine M. Bever

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine M. Bever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine M. Bever. The network helps show where Katherine M. Bever may publish in the future.

Co-authorship network of co-authors of Katherine M. Bever

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine M. Bever. A scholar is included among the top collaborators of Katherine M. Bever based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine M. Bever. Katherine M. Bever is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Luke, Jason J., Katherine M. Bever, F. Stephen Hodi, et al.. (2025). Rationale and feasibility of a rapid integral biomarker program that informs immune-oncology clinical trials: the ADVISE trial. Journal for ImmunoTherapy of Cancer. 13(5). e011170–e011170. 2 indexed citations

Duncan, Mark W., et al.. (2024). Cross-sectional imaging of gastric cancer: pearls, pitfalls and lessons learned from multidisciplinary conference. Abdominal Radiology. 49(12). 4400–4415.

Daud, Adil, Vamsidhar Velcheti, Katherine M. Bever, et al.. (2024). Efficacy, safety, and PK/PD of LVGN6051, 4-1BB agonistic antibody, with pembrolizumab in a phase Ib dose expansion in resistant NSCLC, melanoma, and GI malignancy.. Journal of Clinical Oncology. 42(16_suppl). 2575–2575.

Christenson, Eric S., Jennifer N. Durham, Hao Wang, et al.. (2024). A phase 2 study evaluating response and biomarkers in patients with microsatellite stable (MSS) advanced colorectal cancer (CRC) treated with nivolumab/relatlimab.. Journal of Clinical Oncology. 42(16_suppl). 3554–3554. 1 indexed citations

Huff, Amanda L., Anna Ferguson, Jiayun Lu, et al.. (2024). Abstract CT022: Mutant KRAS peptide-based vaccine in patients at high risk of developing pancreatic cancer: Preliminary analysis from a phase I study. Cancer Research. 84(7_Supplement). CT022–CT022. 7 indexed citations

Kelly, Ronan J., Katherine M. Bever, Joseph Chao, et al.. (2023). Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gastrointestinal cancer. Journal for ImmunoTherapy of Cancer. 11(6). e006658–e006658. 14 indexed citations

Durham, Jennifer N., Su Jin Lim, Katherine M. Bever, et al.. (2023). Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic Cancer. Cancer Research Communications. 3(8). 1672–1677. 5 indexed citations

Christenson, Eric S., Su Jin Lim, Jennifer N. Durham, et al.. (2022). Cell-free DNA Predicts Prolonged Response to Multi-agent Chemotherapy in Pancreatic Ductal Adenocarcinoma. Cancer Research Communications. 2(11). 1418–1425. 8 indexed citations

Christenson, Eric S., Hao Wang, Mark Yarchoan, et al.. (2022). Solid Organ Transplantation Is Associated with an Increased Rate of Mismatch Repair Deficiency and PIK3CA Mutations in Colorectal Cancer. Current Oncology. 30(1). 75–84. 2 indexed citations

10.

Bever, Katherine M., Hao Wang, Jennifer N. Durham, et al.. (2022). 711 Interim results of a phase 2 study of nivolumab and relatlimab in advanced mismatch repair deficient (dMMR) cancers resistant to prior PD-(L)1 inhibition. Regular and Young Investigator Award Abstracts. A744–A744. 3 indexed citations

11.

Bever, Katherine M., Dwayne L. Thomas, Jiajia Zhang, et al.. (2021). A feasibility study of combined epigenetic and vaccine therapy in advanced colorectal cancer with pharmacodynamic endpoint. Clinical Epigenetics. 13(1). 25–25. 18 indexed citations

12.

Wu, Annie A., Katherine M. Bever, Won Jin Ho, et al.. (2020). A Phase II Study of Allogeneic GM-CSF–Transfected Pancreatic Tumor Vaccine (GVAX) with Ipilimumab as Maintenance Treatment for Metastatic Pancreatic Cancer. Clinical Cancer Research. 26(19). 5129–5139. 91 indexed citations

13.

Bever, Katherine M., Hao Wang, Jennifer N. Durham, et al.. (2020). Phase II study of nivolumab and relatlimab in advanced mismatch repair deficient (dMMR) cancers resistant to prior PD-(L)1 inhibition.. Journal of Clinical Oncology. 38(4_suppl). TPS839–TPS839. 6 indexed citations

14.

Bever, Katherine M. & Dung T. Le. (2018). DNA repair defects and implications for immunotherapy. Journal of Clinical Investigation. 128(10). 4236–4242. 61 indexed citations

15.

Bever, Katherine M. & Dung T. Le. (2017). An Expanding Role for Immunotherapy in Colorectal Cancer. Journal of the National Comprehensive Cancer Network. 15(3). 401–410. 39 indexed citations

16.

Bever, Katherine M., Luke Masha, Fangui Sun, et al.. (2015). Risk factors for venous thromboembolism in immunoglobulin light chain amyloidosis. Haematologica. 101(1). 86–90. 22 indexed citations

17.

Bever, Katherine M., Elizabeth A. Sugar, Elaine Bigelow, et al.. (2014). The prognostic value of stroma in pancreatic cancer in patients receiving adjuvant therapy. HPB. 17(4). 292–298. 60 indexed citations

18.

Bigelow, Elaine, Katherine M. Bever, Allison Yager, et al.. (2013). Immunohistochemical Staining of B7-H1 (PD-L1) on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue. Journal of Visualized Experiments. 19 indexed citations

19.

Bigelow, Elaine, Katherine M. Bever, Haiying Xu, et al.. (2013). Immunohistochemical Staining of B7-H1 (PD-L1) on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue. Journal of Visualized Experiments. 41 indexed citations

20.

Avalos‬, José L., Katherine M. Bever, & Cynthia Wolberger. (2005). Mechanism of Sirtuin Inhibition by Nicotinamide: Altering the NAD+ Cosubstrate Specificity of a Sir2 Enzyme. Molecular Cell. 17(6). 855–868. 371 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact